NIH launches clinical study into mixed COVID-19 vaccine schedule
The National Institutes of Health yesterday announced the start of a phase 1/2 clinical trial to investigate the safety and immunogenicity of mixed boosted COVID-19 vaccination regimens. Fully-vaccinated trial participants will receive booster doses of different COVID-19 vaccines and then be followed for one year to allow for the evaluation of safety and other post-vaccination side effects. The initial trial results are expected in late summer 2021.
Related News Articles
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…